Arkstone Medical Solutions (Arkstone), based in Florida (US), was founded in 2018 by three co-founders with backgrounds in software, clinical content, and customer operations. Arkstone is a pioneer in infectious disease clinical guidance and antimicrobial stewardship based on Machine Learning (ML) and generative Artificial Intelligence (gen AI), providing clinical decision support helping healthcare providers optimize antimicrobial use.

Arkstone’s flagship OneChoice Report leverages ML and gen AI to provide optimal infectious disease treatment recommendations. OneChoice analyzes laboratory results alongside patient data and delivers guidance to clinicians. Already in use by over 150 laboratories across the US and internationally, Arkstone is transforming how healthcare providers diagnose, treat, and understand infectious diseases.